Enanta Pharmaceuticals Stock Analysis

Enanta Stock Analysis Notes

About 94.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enanta Pharmaceuticals has Price/Earnings (P/E) ratio of 366.13. The entity recorded a loss per share of 5.45. The firm had not issued any dividends in recent years. Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. Enanta Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 155 people. To learn more about Enanta Pharmaceuticals call Jay Luly at 617 607 0800 or check out https://www.enanta.com.

Enanta Pharmaceuticals Investment Alerts

Enanta Pharmaceuticals Upcoming and Recent Events

Enanta Largest EPS Surprises

View All Earnings Estimates

Enanta Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Enanta Pharmaceuticals Thematic Classifications

Enanta Stock Institutional Investors

Note, although Enanta Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enanta Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 190.91 M.

Enanta Profitablity

The company has Profit Margin (PM) of (1.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.35) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.35.

Management Efficiency

Enanta Pharmaceuticals has return on total asset (ROA) of (0.1718) % which means that it has lost $0.1718 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5964) %, meaning that it created substantial loss on money invested by shareholders. Enanta Pharmaceuticals' management efficiency ratios could be used to measure how well Enanta Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.32. The current year's Return On Capital Employed is expected to grow to -0.38. At present, Enanta Pharmaceuticals' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 5.8 M, whereas Total Assets are forecasted to decline to about 327.6 M.

Technical Drivers

As of the 27th of November, Enanta Pharmaceuticals shows the Mean Deviation of 2.08, coefficient of variation of (475.62), and Standard Deviation of 2.53. Enanta Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enanta Pharmaceuticals Price Movement Analysis

Enanta Pharmaceuticals Insider Trading Activities

Enanta Pharmaceuticals Outstanding Bonds

Enanta Pharmaceuticals Predictive Daily Indicators

Enanta Pharmaceuticals Corporate Filings

Enanta Pharmaceuticals Forecast Models

Enanta Pharmaceuticals' time-series forecasting models are one of many Enanta Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enanta Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enanta Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enanta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enanta Pharmaceuticals. By using and applying Enanta Stock analysis, traders can create a robust methodology for identifying Enanta entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enanta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enanta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Enanta Pharmaceuticals stock analysis indicators help investors evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By understating and applying Enanta Pharmaceuticals stock analysis, traders can identify Enanta Pharmaceuticals position entry and exit signals to maximize returns.

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.